Abbv stock price analysts forecast ABBV stock price

Analysts forecast ABBV stock price could test the $170 resistance level in the coming weeks, driven by strong earnings guidance and a diversified therapeutic portfolio. AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions. Why Options Traders Are Betting Big on Oracle Stock Options market data shows bullish call positioning on ABBV stock price, hinting that traders expect further near-term appreciation.